Giant lung bulla as a late-onset complication of mild SARS-CoV-2 pneumonia
Abstract
A 49-year-old Caucasian man was admitted to the Emergency Department for shortness of breath and cough. Computed tomography (CT) imaging showed bilateral mild COVID-19-related pneumonia. He was hospitalized in the low-intensity COVID-19 unit, where he received O2 therapy and oral corticosteroids. Three weeks after discharge, a high-resolution CT (HRCT) found a giant bulla in the inferior lobe. The bulla was resected by video-assisted thoracoscopic surgery, and the patient recovered completely. In our patient, it is reasonable to suspect that the development of the bulla is a result of SARS-CoV-2 infection since no bulla was observed in the first HRCT two months before. SARS-CoV-2-related pneumonia may be responsible for lung remodeling due to diffuse alveolar damage and later interstitial myofibroblastic proliferation. Corticosteroids might have played a role in increasing SARS-CoV-2 dystrophic action. COVID-19 leads to pulmonary damages, which are still partially unknown and might result in the development of bullae. In fit patients, surgical treatment can be carried out safely.
References
- Tsatsakis A, Calina D, Falzone L, et al. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol 2020;146:111769.
- Özdemir S, Bilgi DÖ, Köse S, Oya G. Pneumothorax in patients with coronavirus disease 2019 pneumonia with invasive mechanical ventilation. Interact Cardiovasc Thorac Surg 2021;32:351-5.
- Yasukawa K, Vamadevan A, Rollins R. Bulla formation and tension pneumothorax in a patient with COVID-19. Am J Trop Med Hyg 2020;103:943-4.
- Murayama D, Kojima D, Hino A, et al. A case of bulla formation after treatment for COVID-19 pneumonia. Radiol Case Rep 2021;16:1162-4.
- Liu K, Zeng Y, Xie P, et al. COVID-19 with cystic features on computed tomography: a case report. Medicine 2020;99:e20175.
- Pednekar P, Amoah K, Homer R, et al. Case report: bullous lung disease following COVID-19. Front Med 2021;8:770778.
- Rocco PR, Souza AB, Faffe DS, et al. Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury. Am J Respir Crit Care Med 2003;168:677-84.
- Li J, Liao X, Zhou Y, et al. Association between glucocorticoids treatment and viral clearance delay in patients with COVID-19: a systematic review and meta-analysis. BMC Infect Dis 2021;21:1063.
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2023 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.